🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/05/2006 | 43,79 | 44,35 | 42,67 | 43,16 | -1,37% | 3,85% | 82.982 |
| 03/05/2006 | 45,85 | 46,04 | 43,23 | 43,76 | -4,80% | 6,12% | 231.286 |
| 02/05/2006 | 47,16 | 47,35 | 45,85 | 45,96 | -2,15% | 3,17% | 100.588 |
| 01/05/2006 | 45,85 | 47,16 | 45,85 | 46,97 | +2,45% | 2,86% | 139.728 |
| 28/04/2006 | 45,85 | 45,96 | 45,70 | 45,85 | -0,24% | 0,57% | 42.827 |
| 27/04/2006 | 45,96 | 46,04 | 45,29 | 45,96 | -0,16% | 1,63% | 45.418 |
| 26/04/2006 | 46,41 | 46,41 | 45,93 | 46,04 | -0,81% | 1,05% | 37.323 |
| 25/04/2006 | 47,31 | 47,61 | 46,04 | 46,41 | -1,98% | 3,32% | 154.529 |
| 24/04/2006 | 47,54 | 47,72 | 46,26 | 47,35 | -1,09% | 3,07% | 181.860 |
| 21/04/2006 | 47,99 | 48,28 | 47,16 | 47,87 | -0,47% | 2,34% | 104.863 |
| 20/04/2006 | 49,18 | 49,18 | 47,99 | 48,10 | -1,91% | 2,44% | 57.895 |
| 19/04/2006 | 47,54 | 49,15 | 47,16 | 49,03 | +2,75% | 4,17% | 94.337 |
| 18/04/2006 | 47,16 | 47,72 | 46,79 | 47,72 | +0,79% | 1,98% | 74.807 |
| 17/04/2006 | 47,91 | 48,21 | 46,79 | 47,35 | -1,94% | 2,97% | 149.667 |
| 13/04/2006 | 48,62 | 48,66 | 47,72 | 48,28 | -0,77% | 1,92% | 41.144 |
| 12/04/2006 | 48,55 | 48,85 | 48,28 | 48,66 | +0,00% | 1,16% | 164.468 |
| 11/04/2006 | 48,66 | 49,22 | 48,17 | 48,66 | -0,38% | 2,15% | 287.311 |
| 10/04/2006 | 50,16 | 50,53 | 48,47 | 48,85 | -2,47% | 4,10% | 98.745 |
| 07/04/2006 | 50,79 | 51,28 | 50,08 | 50,08 | -3,04% | 2,36% | 61.128 |
| 06/04/2006 | 49,22 | 52,40 | 49,03 | 51,65 | +4,55% | 6,84% | 709.782 |
| 05/04/2006 | 47,65 | 49,41 | 47,54 | 49,41 | +3,69% | 3,93% | 625.304 |
| 04/04/2006 | 47,54 | 47,99 | 47,35 | 47,65 | +0,08% | 1,34% | 218.596 |
| 03/04/2006 | 47,84 | 48,47 | 46,79 | 47,61 | -1,01% | 3,52% | 195.646 |
| 31/03/2006 | 48,28 | 48,58 | 47,80 | 48,10 | -0,77% | 1,63% | 516.006 |
| 30/03/2006 | 47,16 | 48,77 | 47,16 | 48,47 | +0,86% | 3,41% | 119.317 |
| 29/03/2006 | 48,47 | 48,66 | 47,91 | 48,06 | -0,85% | 1,54% | 74.192 |
| 28/03/2006 | 49,33 | 49,41 | 48,13 | 48,47 | -2,63% | 2,58% | 49.212 |
| 27/03/2006 | 49,78 | 49,97 | 49,03 | 49,78 | +0,00% | 1,88% | 111.756 |
| 24/03/2006 | 49,59 | 49,89 | 49,03 | 49,78 | -0,37% | 1,74% | 87.203 |
| 23/03/2006 | 50,34 | 50,34 | 49,41 | 49,97 | -0,74% | 1,86% | 36.575 |